An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial.

MLA

Venechuk, Grace E., et al. “An Electronically Delivered, Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure with Reduced Ejection Fraction: Rationale and Design of the EPIC-HF Trial.” American Heart Journal, vol. 229, Nov. 2020, pp. 144–55. EBSCOhost, https://doi.org/10.1016/j.ahj.2020.08.013.

APA

Venechuk, G. E., Khazanie, P., Page II, R. L., Knoepke, C. E., Helmkamp, L. J., Peterson, P. N., Pierce, K., Thompson, J. S., Huang, J., Strader, J. R., Dow, T. J., Richards, L., Trinkley, K. E., Kao, D. P., McIlvennan, C. K., Magid, D. J., Buttrick, P. M., Matlock, D. D., Allen, L. A., & Page, R. L., 2nd. (2020). An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. American Heart Journal, 229, 144–155. https://doi.org/10.1016/j.ahj.2020.08.013

Chicago

Venechuk, Grace E., Prateeti Khazanie, Robert L. Page II, Christopher E. Knoepke, Laura J. Helmkamp, Pamela N. Peterson, Kenneth Pierce, et al. 2020. “An Electronically Delivered, Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure with Reduced Ejection Fraction: Rationale and Design of the EPIC-HF Trial.” American Heart Journal 229 (November): 144–55. doi:10.1016/j.ahj.2020.08.013.